T1	Chemical 77 81	ADMA
T11	Chemical 435 439	ADMA
T12	Disease 458 476	cognitive deficits
#3	AnnotatorNotes T12	DOID:1561
T13	Chemical 542 546	ADMA
T15	Disease 1044 1060	spatial deficits
#5	AnnotatorNotes T15	not found
T16	Chemical 1153 1157	ADMA
T19	Chemical 1231 1235	ADMA
T2	Chemical 157 161	ADMA
T22	Drug 1324 1333	melatonin
T23	Chemical 1377 1381	ADMA
T24	Drug 1439 1448	melatonin
T25	Chemical 1479 1483	ADMA
T26	Drug 1579 1588	melatonin
T27	Chemical 1610 1614	ADMA
T28	Disease 1653 1667	brain disorder
#18	AnnotatorNotes T28	DOID:936
T3	Drug 203 226	ornithine phenylacetate
T5	Disease 283 298	liver cirrhosis
#21	AnnotatorNotes T5	DOID:5082
T6	Biomarker 306 327	cognition dysfunction
#22	AnnotatorNotes T6	D060825
T8	Chemical 345 349	ADMA
T7	Biomarker 71 114	brain ADMA levels were significantly higher
#1	AnnotatorNotes T3	CHEMBL4297204
T4	Biomarker 332 356	higher serum ADMA levels
T10	Collection 306 356	cognition dysfunction and higher serum ADMA levels
R1	Association Arg1:T10 Arg2:T5	
T14	Biomarker 418 446	increased plasma ADMA levels
T9	Biomarker 532 553	increased ADMA levels
T17	Biomarker 1221 1249	increased ADMA concentration
#2	AnnotatorNotes T22	CHEMBL45
T18	Biomarker 1139 1164	difference in ADMA levels
